DE

DoubleLine Equity Healthcare Fund

Description

DoubleLine Equity Healthcare Fund

Investor Profile

DoubleLine Equity Healthcare Fund has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DoubleLine Equity Healthcare Fund frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Tekla Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Jennison Associates
North America, New York, United States, New York
Co-Investments: 1
CI
North America, New York, United States, New York
Co-Investments: 1
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Sphera Funds Management
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by DoubleLine Equity Healthcare Fund?

Ovid Therapeutics

New York, New York, United States

Ovid Therapeutic's purpose is to solve intractable medical problems.

BiopharmaBiotechnologyHealth Care
Series BAug 11, 2015
Amount Raised: $75,000,000